Search results
Found 21 matches for
The US Food and Drug Administration (FDA) has recently licensed a form of ketamine – esketamine – as a treatment for depression which is resistant to other treatments. It is administered as a nasal spray in a clinic, initially twice a week, then weekly or fortnightly. Regular doses of the drug are necessary to prevent relapse.
Translational NeuroStimulation Laboratory
Anxiety Behaviour Brain function Brain imaging Cognitive models Decision-making Depression Disorders Evidence based treatment Experimental Functional imaging Information processing Magnetic Resonance Imaging (MRI) Mood Neuroscience Psychological therapy Psychology Therapy
We aim to understand processes of selective attention and action, learning and memory in the human brain. Through experiments in healthy volunteers and patients with brain disorders we seek to characterize how information processing networks respond (adaptively or maladaptively) when challenged by interference. Our motivation is to develop rational neurocognitive intervention strategies to help promote recovery from conditions such as depression and brain injury.